Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Elan Corp., plc (NYSE:ELN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider | Options | Reports
Location
Lincoln House, Lincoln Place
Dublin 2, Ireland
Phone: (212) 407-5740
Fax: (212) 755-1043
Email: jhowarth@elancorp.com
Employees (last reported count): 4,472
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 16%
·Institutional: 56% (67% of float)
(885 institutions)
·Net Inst. Buying: 8.62M shares (+4.53%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Elan Corporation, plc is a worldwide pharmaceutical and biotechnology company focused on the development and commercialization of products. Elan focuses on drug delivery systems and has expanded its therapeutic focus through the development and commercialization of new pharmaceutical products for the selected target markets of neurology, pain management and oncology. Elan currently conducts its operations through two primary business units: Elan Pharmaceuticals (EP) and Elan Pharmaceutical Technologies (EPT). EP is engaged in the discovery, development and marketing of therapeutic products for neurological disorders and pain management, as well as diagnostic services for neurological disorders. EP's principal research and development activities focus on Alzheimer's disease, pain management, epilepsy, multiple sclerosis, Parkinson's disease, dystonias and other neurological disorders. EPT is engaged in the development, licensing and marketing of drug delivery products and technologies.
More from Market Guide: Expanded Business Description

Financial Summary
Elan is a specialty pharmaceutical company focused on the discovery, development and marketing of therapeutic products and services in neurology, pain management and oncology. For the six months ended 6/30/01, revenues rose 26% to $890.6 million. Net income before acct. change totalled $210.7 million, vs. a loss of $47 million. Results reflect increased product sales reflecting the execution of several new licenses and lower charges related to merger costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
Donal Geaney, 49Chairman and CEO
John Groom, 62Pres, COO
Thomas Lynch, 43Vice Chairman
Shane CookeCFO, Exec. VP, Director
William ClarkPres, Elan Pharmaceutical Operations
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:ELNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 9-Jan-2001
$42.75 
Recent Price$51.95 
52-Week High
on 20-June-2001
$65.00 
Beta0.37 
Daily Volume (3-month avg)1.46M
Daily Volume (10-day avg)1.36M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-11.1%
52-Week Change
relative to S&P500
+19.3%
Share-Related Items
Market Capitalization$16.8B
Shares Outstanding322.5M
Float270.9M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 7-June-1999
Per-Share Data
Book Value (mrq)$8.52 
Earnings (ttm)$1.58 
Earnings (mrq)$0.37 
Sales (ttm)$4.62 
Cash (mrq)$4.61 
Valuation Ratios
Price/Book (mrq)6.10 
Price/Earnings (ttm)32.78 
Price/Sales (ttm)11.24 
Income Statements
Sales (ttm)$1.60B
EBITDA (ttm)$475.7M
Income available to common (ttm)$545.9M
Profitability
Profit Margin (ttm)34.2%
Operating Margin (ttm)29.8%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)12.06%
Return on Equity (ttm)22.57%
Financial Strength
Current Ratio (mrq)2.20 
Debt/Equity (mrq)0.57 
Total Cash (mrq)$1.55B
Short Interest
As of 8-Aug-2001
Shares Short15.6M
Percent of Float5.8%
Shares Short
(Prior Month)
16.1M
Short Ratio10.68 
Daily Volume1.46M
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.